Product Information
SERTRALINE HCL 25 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0286 per EA under NDC 68180097802. Its NADAC has been published 34 times since Nov 5, 2025.
Strength
25 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180097802
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077670On Market Since
7/20/2025
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE HCL 25 MG TABLET has been published 34 times since Nov 5, 2025, and over the history we have for it it has declined 14.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0286 per EA |
|---|---|
| All-time high | $0.0336 (Nov 12, 2025) |
| All-time low | $0.0286 (Jun 17, 2026) |
| 52-week high | $0.0336 |
| 52-week low | $0.0286 |
| Median price | $0.0320 |
| Average price | $0.0317 |
| Largest weekly change | -5.6% (Apr 22, 2026) |
| Weeks tracked | 34 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SERTRALINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE HCL 25 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.0286 per EA (NDC 68180097802), effective Jun 24, 2026.
How has the price of SERTRALINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for SERTRALINE HCL 25 MG TABLET has declined 14.8%. It has been tracked across 34 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for SERTRALINE HCL 25 MG TABLET?
Since Nov 5, 2025, the NADAC for SERTRALINE HCL 25 MG TABLET has ranged from a low of $0.0286 (Jun 17, 2026) to a high of $0.0336 (Nov 12, 2025), with a median of $0.0320 per EA.
Are there cheaper alternatives to SERTRALINE HCL 25 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as SERTRALINE HCL 25 MG TABLET, but none are currently priced below it.
Who manufactures SERTRALINE HCL 25 MG TABLET?
SERTRALINE HCL 25 MG TABLET (NDC 68180097802) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification